Reed Wilcox is the President of Southern Virginia University. Reed co-founded Clene Nanomedicine. Prior to Clene Nanomedicine, President Wilcox was co-founder and senior managing director of General Resonance. Earlier, Reed... read more →
Mr. Gay is a Managing Partner at Kensington-SV Global Innovations LP (KSV), a growth stage investment firm which he co-founded in 2018. Prior to joining KSV, Mr. Gay was Managing... read more →
Vallerie V. McLaughlin, MD, is the Kim A. Eagle MD Endowed Professor of Cardiovascular Medicine, and Director of the Pulmonary Hypertension Program at the University of Michigan in Ann Arbor.... read more →
John Stevens, MD, currently serves as the chairman and CEO of Heartflow, Inc, a provider of noninvasive cardiovascular imaging technology, and as the managing partner of Headwaters Capital Partners. John... read more →
Shalom “Shal” Jacobovitz is the chief executive officer of CIVI Bio, a privately held biopharmaceutical, and the former CEO of the American College of Cardiology. In this role at the... read more →
Chidozie Ugwumba serves as Managing Partner of SymBiosis, a venture capital firm focused on investments in biotherapeutics. At SymBiosis, Mr. Ugwumba leads sourcing, due diligence, and execution of investments, and... read more →
Alison Mosca is a Managing Director & CEO of Kensington Capital Holdings. Prior to founding Kensington Capital Holdings, Alison built a multi-family office within Audax Group, a leading middle market... read more →
Mr. Etherington brings nearly 30 years of sales, marketing and leadership experience in the pharmaceutical industry to Clene. Prior to joining Clene as CEO, Mr. Etherington worked for Actelion Pharmaceuticals,... read more →
David Matlin has been on our board of directors since December 2020 and chairman of our board since May 2021, and is in charge of supervising and providing independent judgement... read more →